Sunday, April 28, 2024
ADVT 
International

Majority of employees killed and wounded in shooting at a FedEx facility in Indianapolis from the Sikh Community

Darpan News Desk Darpan, 16 Apr, 2021 08:53 PM
  • Majority of employees killed and wounded in shooting at a FedEx facility in Indianapolis from the Sikh Community

Tragedy struck at a FedEx facility in Indianopolis Thursday night after 9 people were killed including the gunman who opened fire late Thursday. 

No police officers were hurt in the shooting but the shooter was a former employee of FedEx. 

The shooter has been identified as 19-year-old Brandon Scott Hole of Indiana. Investigators searched the shooter's home  and seized desktop computers and other electronic media. 

According to Indiana police the motive of the gunman on opening fire Thursday night at a FedEx processing centre near the Indianapolis airport is not known. The shooter started randomly firing at people in the parking lot and then went into the building and continued shooting. 

Most employees aren't allowed to have cellphones inside the FedEx building, making contact with them difficult and to know what happened to loved ones made the wait for the families even worse. 

FedEx said in a statement that cellphone access is limited to a small number of workers in the dock and package sorting areas to “support safety protocols and minimize potential distractions.”

4 people were killed outside the building and another 4 inside. Several people were also injured including 5 who were taken to hospital. 

The victims names and identities have not been released.

The majority of employees at the FedEx facility are members of the Sikh community. The Sikh Coalition issued a statement on Twitter saying it was “deeply saddened to learn” that Sikh community members were among the wounded and killed.

Vice President of the US Kamala Harris shared her sorrow over the sensless violence in Indianapolis.

House Speaker Nancy Pelosi shared her anger and grief over Twitter.

The killings marked the latest in a recent spate of mass shootings across the nation and the third mass shooting this year in Indianapolis.

MORE International ARTICLES

Extra safety scrutiny planned as virus vaccine worries grow

Extra safety scrutiny planned as virus vaccine worries grow
The poll from The Associated Press-NORC Center for Public Affairs Research found only 46% of Americans want a COVID-19 vaccine and another 29% are unsure.

Extra safety scrutiny planned as virus vaccine worries grow

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout
The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19